Minority shareholder Dr. Shilpi Gang has moved the NCLT against ASG Hospitals co-founder Dr. Arun Singhvi. The petition alleges mismanagement and breach of contract regarding a proposed ₹450 crore funding plan. Dr. Gang seeks to block amendments to company bylaws that she claims would weaken her shareholder protections.
Detailed Coverage
A legal dispute has emerged within the eye-care chain ASG Hospitals, as minority shareholder Dr. Shilpi Gang has filed a petition with the National Company Law Tribunal (NCLT). The legal action targets co-founder Dr. Arun Singhvi, Chief Financial Officer Dalpat Raj Jain, and several investment entities associated with the hospital chain's ownership. The petition claims oppression and mismanagement, marking a notable escalation in internal governance disputes.
Conflict Over Shareholder Agreements
The central issue of the petition is a proposed ₹450 crore financing deal. Dr. Gang alleges that the company intends to amend its Articles of Association to facilitate this transaction, which she argues would directly violate existing shareholder agreements. By filing under Sections 241 and 242 of the Companies Act, which are specifically designed to address cases of oppression and mismanagement, she is seeking judicial intervention to prevent these changes. Dr. Gang maintains that these amendments would undermine the contractual rights established to protect her interest as a minority shareholder.
Institutional Ownership and Growth
ASG Hospitals, which traces its origins to a 2005 partnership in Jodhpur, has expanded into a large network with roughly 180 centers across 95 cities. Its growth has been supported by significant private equity interest. In 2022, a consortium including General Atlantic, Kedaara Capital, and entities under the Sky Impact umbrella invested approximately ₹1,500 crore into the chain. These institutional investors currently hold a combined stake of about 70% in the company. The involvement of these large institutional backers in the current restructuring highlights the complexity of the ongoing governance challenge.
Investor Monitorables
For those tracking the company’s progress, the primary focus remains the NCLT’s response to the petition. The outcome of this case could determine whether the company proceeds with the ₹450 crore funding plan as originally structured or if it must negotiate alternative terms. Beyond the immediate legal hurdle, investors may monitor how this dispute influences the company’s ability to execute its planned expansion, manage its leadership stability, and maintain relationships with its institutional partners. The tribunal’s future hearings will clarify whether the proposed amendments to the company’s bylaws will be permitted or halted pending further resolution.